Measuring Metabolism in Tumor Spheroids

A spheroid is a gradient, and every measurement is an average over it.

The geometry decides the biology

Oxygen diffuses roughly 100–200 µm into tissue before being consumed. A spheroid of 400 µm diameter therefore has an outer proliferating rim, an intermediate quiescent zone, and a core that is hypoxic or necrotic.

DiameterCompositionWhat a bulk measurement reports
< 200 µmMostly normoxic, proliferatingA reasonable approximation of a cell
200–400 µmRim plus hypoxic coreAn average of two populations
> 500 µmRim, quiescent zone, necrotic coreAn average that is dominated by dead cells

Important distinction. A spheroid "metabolic phenotype" measured at day 10 is a different object from the same line measured at day 3. Growth day is a variable with a larger effect than most treatments, and it is frequently unreported.

Size control

ApproachMethodConsequence
Seeding densityFixed cell number per well, non-adhesive plateStandard; size still varies
FiltrationForce through a meshNarrow distribution; shear stress
Hanging dropFixed volume per dropVery uniform; low throughput
Microfluidic trappingPhysical confinementUniform; specialised equipment
CentrifugationPellet formationFast; density gradients

Whatever the method, the distribution should be reported, not a mean. A culture with a mean of 400 µm and a range of 200–700 µm contains three different tissues.

What can be measured, and how

MeasurementMethodLimitation
Oxygen consumptionExtracellular flux with spheroid embeddingDiffusion within the plate; edge effects
GlycolysisLactate accumulation in conditioned mediumIncludes core-derived lactate
Metabolite poolsBulk mass spectrometry after dissociationDissociation changes pools within minutes
Labelled flux¹³C on pooled spheroidsRequires many spheroids; average over zones
Per-zone analysisSectioning, or spatial methodsLow throughput; preserves architecture
Viability gradientsLive/dead staining with confocalPenetration of the dye itself

Readout note. For extracellular flux on intact spheroids, the measured rate is limited by diffusion from the core to the sensor as well as by metabolism. Two spheroids of the same size but different density will differ in apparent flux because of diffusion, not biology. This can be partially controlled by comparing size-matched spheroids and by using a cell-number-matched 2D control.

Lactate and glucose in conditioned medium

Spheroid medium measurements are the most accessible and the most misinterpreted.

QuantityWhat it reportsConfounder
Glucose depletionNet consumption by the whole spheroidCore cells may be consuming nothing
Lactate accumulationNet releaseCore may be re-consuming lactate
Lactate/glucose ratioNet exchange ratioNot per-cell; not per-zone
AmmoniaGlutaminolysisMedium degradation contributes

The last point in the third row is the key one: in a spheroid with a hypoxic core, lactate produced at the rim can be oxidised in the core, so the net release understates production. The ratio is a net balance, not a rate.

Dissociation or not

ApproachPreservesLoses
Intact spheroidArchitecture, gradientsPer-cell attribution
Enzymatic dissociationPer-cell analysis by flowGradients; stress signature within minutes
SectioningSpatial informationThroughput; z-axis sampling
OutgrowthMigratory and proliferative capacityThe original organisation

Caveat on dissociation. Dissociation induces immediate-early genes and heat shock responses within minutes, and the hypoxic core cells are the most fragile. A single-cell profile of a dissociated spheroid is biased toward the cells that survived dissociation, which are the rim cells — exactly the population that was already over-represented.

What a spheroid can and cannot support

ClaimSupportableWhy
Nutrient gradient existsYesMeasured by reporters or sectioning
Cells at the core are hypoxicYesWith a validated reporter and size control
The population shifts to glycolysisPartlyNet exchange; not per-zone
Drug penetrates poorlyYesWith imaging or a penetration assay
This is a model of the tumour microenvironmentPartlyNo vasculature, no immune cells, no stroma
This recapitulates patient heterogeneityRarelyClonal selection in culture

Important distinction. A spheroid adds geometry and gradients. It does not add vasculature, immune cells, fibroblasts or systemic supply. The word "microenvironment" in a spheroid paper usually means "gradient", and the claim should say which features are present.

Practical parameters

ParameterTypical valueNote
Seeding density500–2,000 cells per well (96-well, round-bottom, ultra-low attachment)Line-dependent
Medium changeEvery 2–3 days, half-volumeAvoid disturbing the spheroid
Size at assay300–500 µmBeyond that, the necrotic fraction dominates
Spheroids per condition≥ 8–12Size heterogeneity is the variance source
Equilibration for flux1 h in assay bufferDiffusion equilibrium is slower than in 2D

Failures that recur

  • • Size unreported. The single largest confounder.
  • • Mean diameter reported without a distribution.
  • • Day 10 spheroids used as "3D culture" without acknowledging the necrotic core.
  • • Lactate release reported as production. The core re-consumes it.
  • • Dissociated cells profiled and called "spheroid cells". The rim is over-represented.
  • • 2D control not matched for cell number, so the comparison is between different amounts of tissue.
  • • "Tumour microenvironment" claimed without stroma or immune cells.

Where this connects

  • • Tumour metabolic dependency article supplies the environment argument: dependency measured in 2D may not exist in a gradient.
  • • Mitochondrial pillar supplies the oxygen and HIF logic that the gradient imposes.
  • • Disease pillar supplies the model-tier framing: a spheroid sits between a line and an animal, and supports a specific subset of claims.

Scientific interpretation and experimental design

  • • Report size distribution and day.
  • • Match sizes across conditions.
  • • Match cell number against the 2D control.
  • • Treat net exchange as a balance, not a rate.
  • • Do not dissociate and call it representative. The rim survives.
  • • Name the features the model actually has. Gradient, not microenvironment.
  • • Use per-zone methods when the claim is about zones.

Selected references for further reading

  • • Hirschhaeuser F, et al. Multicellular tumor spheroids: an underestimated tool is catching up again. Journal of Biotechnology. 2010;148:3–15.
  • • Riffle S, Hegde RS. Modeling tumor cell adaptations to hypoxia in multicellular tumor spheroids. Journal of Experimental & Clinical Cancer Research. 2017;36:102.
  • • Friedrich J, Seidel C, Ebner R, Kunz-Schughart LA. Spheroid-based drug screen: considerations and practical approach. Nature Protocols. 2009;4:309–324.
  • • Place TL, Domann FE, Case AJ. Limitations of oxygen delivery to cells in culture: an underappreciated problem in basic and translational research. Free Radical Biology and Medicine. 2017;113:311–322.

Related Products

Product name Cat.No. Species Gene ID
PBRM1 Knockout A-549 Cell Line EDJ0001-K01 Human 55193 Details Get a Quote
YTHDC1 Knockout A-549 Cell Line EDC07652 Human 91746 Details Get a Quote
TP53 Knockout HCT 116 Cell Line EDC07854 Human 7157 Details Get a Quote
Sirt2 Knockout MH-S Cell Line EDJ-KQ78173 Mouse 64383 Details Get a Quote
TFE3 Knockout KGN Cell Line EDJ-KQ48 Human 7030 Details Get a Quote
Stub1 Knockout MB49 Cell Line EDJ-KQ53 Mouse 56424 Details Get a Quote
ARID1A Knockout SNK-6 Cell Line EDJ-KQ64 Human 8289 Details Get a Quote
Tet1 Knockout Kupffer Cell Line EDJ-KQ88 Mouse 52463 Details Get a Quote
NR1H3 Knockout HEK293T Cell Line EDJ-KQ109 Human 10062 Details Get a Quote
NR1H2 Knockout HEK293T Cell Line EDJ-KQ110 Human 7376 Details Get a Quote
RPS6KB2 Knockout HEK293 Cell Line EDJ-KQ125 Human 6199 Details Get a Quote
SMAD6 Knockout HEK293 Cell Line EDJ-KQ126 Human 4091 Details Get a Quote
JUN Knockout HEK293 Cell Line EDJ-KQ176 Human 3725 Details Get a Quote
JUN Knockout HEK293T Cell Line EDJ-KQ184 Human 3725 Details Get a Quote
ALKBH5 Knockout HEK293 Cell Line EDJ-KQ186 Human 54890 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: